Effect of supplementation in treatment of patients with endometrial hyperplasia

Phase 3

• Conditions: Endometrial hyperplasia.; Endometrial hyperplasia; E11.2

• Registration Number: IRCT201701015623N98
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Aged 35-55 years old
Patients with endometrial hyperplasia

Exclusion Criteria

Menopausal women
History of cardiovascular disease
Hypertension
Untreated thyroid disease
Taking anti-inflammatory agents
Diabetes Mellitus

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to treatment. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Sonography.;Hs-CRP. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.